As the Reserve Bank delivered its first cash rate reduction in over four years in late February 2025, attention swung back to housing affordability—but the easing cycle will not solve the central friction for one of Australia’s highest-earning professional groups. Medical contractors, including locum general practitioners, visiting medical officers, private specialists, and allied health professionals operating on service agreements, routinely find that their income structures fall outside the automated verification engines used by major banks. A junior registrar who transitions to a locum arrangement can double their billings within twelve months, yet the absence of a standard PAYG payslip paired with a full year of tax returns can derail a loan application with a mainstream credit union. The mismatch has become more acute since APRA’s 19 July 2024 confirmation that the mortgage serviceability buffer would hold at 3.0 percentage points above the product rate, a stance that squeezes borrowing capacity precisely when variable incomes are scrutinised more heavily. Non-bank lenders, reading the payroll data, have moved to construct alt-doc pathways that treat AHPRA registration, accountant-certified income, and even Medicare service statements as proxies for the missing payslip. For a doctor earning $350,000 per annum but with only six months of self-employed history, this shift is the difference between a loan decline and a settlement at market-competitive rates.
The Medical Professional’s Documentation Mismatch
Why Standard PAYG Verification Fails Locum Doctors
The typical locum doctor operates through a service entity—either a personal company or as a sole trader—invoicing hospitals, clinics, or telehealth platforms on a per-session or per-shift basis. Income arrives as gross business receipts, often with irregular frequency, and the doctor is responsible for their own superannuation, professional indemnity insurance, and tax provisions. A major bank’s credit assessor, applying the NCCP-mandated responsible lending guidelines, will commonly request two years of full tax returns and notices of assessment to derive a stable income figure. For a doctor who commenced locum work 10 months prior, that request cannot be met, regardless of a $9,000 weekly contract rate. This creates a lending gap that is now being bridged by non-bank lenders who accept alternative income verification for medical professionals—acknowledging that AHPRA registration itself acts as a quality signal. The income-smoothing method used by these lenders often takes the three most recent consecutive business activity statements, annualises the gross receipts, and applies a fixed expense ratio, typically 20% for medical professionals, to arrive at a net income for serviceability. This is materially faster and reflects the transient cashflows that characterise the medical contractor workforce.
The AHPRA Registration as a Risk-Weighting Tool
Lenders such as La Trobe Financial and Pepper Money have embedded AHPRA registration checks into their credit decision engines, effectively tiering medical borrowers above the general self-employed population. In practice, a borrower who holds current general or specialist registration with the Australian Health Practitioner Regulation Agency satisfies a “professional” criterion that unlocks higher maximum LVRs and, in some products, a reduced serviceability buffer. Pepper’s near-prime product suite, most recently updated in January 2025, permits a 1.0% serviceability buffer for medical professionals where income is supported by a MAS-qualified accountant’s letter, compared with the standard 1.5% buffer for non-professional alt-doc applications. This differential reflects the low default rates observed among registered health practitioners, a data point that credit committees have internalised without requiring public disclosure. The flow-on effect for an anaesthetist billing $400,000 annually can lift their maximum borrowing capacity by approximately $120,000 relative to a generic alt-doc assessment, measured at a 6.20% p.a. variable rate.
Alt-Doc Product Structures: From BAS Statements to Accountant Letters
Low-Doc versus Alt-Doc: The Nuance That Determines Rate and LVR
The Australian non-bank market draws a meaningful distinction between “low-doc” and “alt-doc” labels, even though brokers and consumers often use them interchangeably. A true low-doc product—such as the Resimac Super Select line—requires minimal income evidence, sometimes a simple declaration of income on the application form and an accountant’s certification that the borrower can afford the loan. In exchange, the maximum LVR typically caps at 70% to 75% for a residential purchase, and the interest rate premium can be 1.00–1.50 percentage points above a comparable full-doc rate. Alt-doc, by contrast, refers to a middle ground where specific documents—BAS statements, business bank account transaction summaries, or a profit and loss statement verified by a registered tax agent—are supplied, allowing LVRs up to 80% or even 90% for approved professional categories. For doctors, this alt-doc space is where the most competitive terms are concentrated, with lenders accepting an AHPRA registration certificate alongside a single accounting document to bypass the two-year tax return requirement entirely.
Income Verification Through AHPRA: The Quasi-Full-Doc Lane
A small but growing cohort of non-banks, led by La Trobe Financial, has introduced what amounts to a full-doc serviceability assessment using a medical professional’s annual income declaration verified by AHPRA status, without requiring any tax returns. La Trobe’s Medical Professional Policy, effective 1 March 2025, allows a maximum LVR of 90% inclusive of capitalised LMI for purchases up to $2.5 million, provided the applicant has a minimum two years of AHPRA registration and can supply an accountant’s letter confirming the current year’s income derived from medical practice. The income figure is assessed at 80% of the declared gross to allow for practice costs, and the servicing test is run at the product rate plus a buffer of just 0.50%, a sharp discount to the APRA benchmark. This product essentially treats a registered medical practitioner as a low-risk income stream, a view that aligns with the steady demand for locum doctors across state health systems. Brighten’s Alt Doc Complete product similarly carves out a medical professional category, permitting LVRs up to 85% with a declared income capped at $350,000 per annum for self-employed doctors, using a tax agent’s letter and AHPRA registration as the sole verification documents.
Lender Policy Matrix: Maximum LVRs, DTI Caps, and Eligibility
La Trobe Financial: 90% LVR with a Medical Professional Policy
La Trobe Financial’s specialised medical professional loan is available to physicians, surgeons, anaesthetists, psychiatrists, and other specialists holding AHPRA general or specialist registration for at least two years. The product accepts both PAYG doctors and self-employed doctors, with the latter assessed under an alt-doc income method that takes the accountant-certified current-year earnings and discounts them by 20% for business expenses, unless the borrower provides evidence of lower actual expenses. The maximum LVR is 90% for purchases up to $2.5 million, including LMI premium capitalisation where applicable, and 80% for cash-out refinances. The DTI limit is set at a hard cap of 6.5 times, measured against the assessed net income before tax, and the product carries a 0.65% p.a. risk fee on the drawn balance for the first three years, which can be capitalised. As of June 2025, the variable rate on a $1 million loan with this product stood at 6.85% p.a. (comparison rate 7.12% p.a.), representing a 65-basis-point premium to La Trobe’s equivalent full-doc professional package.
Pepper Money: Near-Prime Speed with MAS-Qualified Income
Pepper Money’s near-prime suite includes a Specific Purpose Loan that can be structured as alt-doc for medical contractors. The lender’s policy, which was tightened in July 2024 to require a registered company accountant or MAS member to certify income, accepts the current year’s income extrapolated from six months of BAS statements or a profit and loss statement. The maximum LVR for a medical professional under this policy is 80% for loans up to $1 million, reducing to 75% for amounts between $1 million and $1.5 million. The DTI cap is 6.0 times, and the serviceability buffer is set at 1.0% for medical professionals compared to the standard 1.5% for other alt-doc applicants. Pepper’s rate card for a $800,000 medical alt-doc loan with a 25-year term quotes a variable rate of 6.45% p.a. (comparison rate 6.89% p.a.) as of May 2025, with no ongoing monthly fees. The application-to-settlement cycle typically runs 12 business days, a speed that has made it the default choice for locum doctors with a signed purchase contract and a short settlement window.
Liberty Financial and Resimac: Flexible Alt-Doc for High-Net-Worth Doctors
Liberty Financial’s “Freedom” range offers an alt-doc pathway that accepts a letter from a qualified accountant stating the borrower’s income derived from medical practice, without requiring BAS statements. The maximum LVR for a medical professional purchase is 75%, and Liberty’s credit committee will consider loans up to $2 million on a case-by-case basis, provided the post-code is metropolitan and the borrower’s net assets exceed $500,000 excluding the subject property. The interest rate on a Liberty alt-doc medical loan starts at 7.10% p.a. variable, with a comparison rate of 7.35% p.a., and carries a $595 annual service fee. Resimac’s Alt Doc Prime product, updated in April 2025, caps LVR at 80% for medical self-employed borrowers who supply an accountant’s declaration and AHPRA registration, with a DTI limit of 6.0. Resimac’s rate for this segment sits at 6.70% p.a. (comparison rate 7.04% p.a.), and the lender applies a 1.0% serviceability buffer for borrowers with credit scores above 700 and a clean repayment history.
Bluestone and Brighten: Niche Policies for Specialised Professionals
Bluestone’s “Specialist Plus” product, launched in October 2024, includes a dedicated medical professional feature that permits a declared income of up to $500,000 to be assessed at 100% for serviceability where the borrower provides a letter from a medical college confirming fellowship and current practice details. The LVR cap is 80% for purchases, and the rate is priced at 6.50% p.a. variable with a comparison rate of 6.77% p.a. Brighten’s Alt Doc Complete product, already mentioned, extends its 85% LVR medical offering to dentists, veterinarians, and pharmacists who hold registration with their respective professional bodies, not just AHPRA-registered doctors. For a senior dentist operating a private clinic and presenting an accountant’s letter, Brighten will assess income at 90% of declared gross for the first $200,000 and 80% thereafter, reflecting the higher consumables cost in dental practices. The rate for a $900,000 Brighten medical alt-doc loan in June 2025 is 6.59% p.a. variable (comparison rate 6.93% p.a.), with an application fee of $990.
Serviceability Math: Rates, Buffers, and the Premium for Flexibility
Comparing Serviceability Buffers Across Medical Alt-Doc Products
The APRA serviceability buffer of 3.0 percentage points, unchanged since 2021 and reaffirmed in its 19 July 2024 letter to ADIs, applies to authorised deposit-taking institutions. Non-ADIs such as Pepper, La Trobe, and Brighten are not directly bound by the buffer, although they adopt internal benchmarks to satisfy their warehouse funders. For medical professionals, these internal buffers range from 0.50% (La Trobe Professional) to 1.0% (Pepper near-prime) to 1.50% (Resimac Alt Doc Prime), dramatically altering maximum loan sizes. Consider a doctor with an assessed net income of $240,000 per annum, no other debts, and a 25-year loan term. At a product rate of 6.50% p.a. and a buffer of 3.0%, the maximum borrowing capacity under the Household Expenditure Measure is approximately $1.22 million. Reduce the buffer to 1.0% and that figure rises to $1.51 million, an increase of $290,000. The La Trobe 0.50% buffer pushes capacity to roughly $1.63 million, assuming identical expense assumptions. For a Sydney-based ophthalmologist aiming to purchase a $2.2 million family home in Hornsby with a 20% deposit, this buffer differential is the decisive factor.
Rate Premiums and the Effective Annual Cost
Non-bank alt-doc rates for medical professionals currently range from 6.45% p.a. to 7.10% p.a. variable, compared with a prime full-doc owner-occupier rate of approximately 6.00% p.a. from a major bank, as at June 2025. The effective annual interest cost differential on a $1 million loan at 6.50% versus 6.00% is $5,000 before tax. Capitalised risk fees or application fees add to the total cost on a net present value basis. La Trobe’s 0.65% risk fee on a $2 million loan (90% LVR for a $2.22 million purchase) capitalises to $11,700 over three years, adding roughly 0.20% p.a. to the effective rate. However, for a doctor whose income will stabilise within two years and who plans to refinance to a full-doc product once two years of tax returns are available, the upfront premium can be a rational cost of bridging the documentation gap. The key metric for the borrower is the break-even period: if refinancing to a 6.00% p.a. full-doc product after 24 months, the total extra interest and fees paid over the alt-doc period must be weighed against the capital growth and rental savings from entering the property market earlier. In a flat Sydney market growing at 3% p.a., a $2 million property foregone for two years represents $120,000 in gross capital appreciation, far exceeding the $14,000–$18,000 combined interest and fee premium of the alt-doc pathway.
Case Study: Locum Anaesthetist Purchasing a $1.5M Primary Residence
A 34-year-old locum anaesthetist with AHPRA specialist registration since 2021 operates through a company structure, billing $420,000 in the current financial year with six-monthly BAS statements showing an average quarterly gross of $105,000. Her accountant certifies current-year net practice income of $320,000 after expenses. She seeks an $1.2 million loan (80% LVR) for a $1.5 million property in Melbourne. Under the La Trobe Medical Professional Policy, the lender assesses income at 80% of $320,000, yielding a serviceability income of $256,000. At the product rate of 6.85% p.a. with a 0.50% buffer, and after deducting household expenditure of $3,200 per month, the loan is comfortably serviced, and the application proceeds with LMI capitalised. The Pepper near-prime alternative, using a 1.0% buffer and 80% LVR, also approves the loan but results in a slightly higher repayment due to a 7% p.a. rate on an $800,000 sub-$1 million tier. The anaesthetist closes in three weeks from application to unconditional approval, paying a rate premium of 0.85% above major-bank full-doc, and intends to refinance after lodging her second full-year tax return in October 2026. The total extra interest over 18 months is $8,100, while the property’s estimated annual growth of 4% would yield $60,000 in the first year alone.
Three Immediate Actions for Medical Borrowers
First, obtain your AHPRA registration certificate and a letter from your accountant dated within the last 30 days that states your current-year income from medical practice, before starting any application. Lenders such as Pepper and Brighten will reject a document that predates the loan application by more than 60 days. Second, run a serviceability estimate across at least two buffers—one based on the APRA 3% buffer used by a reference bank, and one based on a non-bank medical-specific buffer of 1.0%—so you know your price ceiling before bidding. A mortgage broker with access to La Trobe’s Professional calculator can run this scenario in under 10 minutes. Third, structure the loan with an offset account if possible; several medical alt-doc products, including La Trobe’s, permit 100% offset, which allows you to park surplus locum income and reduce the effective interest cost while maintaining redraw flexibility for tax liabilities. Finally, if you are within six months of having two full-year tax returns, consider a bridging alt-doc strategy: fund the purchase with a short-term alt-doc facility, note the exit costs, and schedule a refinance to a full-doc loan with a major bank at the earliest possible date. The rate reduction alone can save $4,000–$7,000 per year on a $1 million balance, and the major bank’s introductory cashback offers—often $2,000–$3,000 for refinances—can offset the discharge and application fees.